What Is Dianthus Therapeutics, Inc. (DNTH) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Dianthus Therapeutics, Inc.'s intrinsic value is estimated at $31.37. Trading at its current price of $99.91, the valuation engine raises significant caution: 11 of 12 models flag downside risk, projecting an average implied return of -68.6%. Model dispersion is worth noting: PWERM targets $96.57 (-3.3%), versus ML-RIV at $1.38 (-98.6%). This +95.3% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About DNTH?
12 of 13 models are currently active for DNTH. All 12 active models suggest the stock trades above fair value. The Bayesian DCF estimates DNTH's intrinsic value at $54.03, implying -45.9% downside from the current price. See which stocks rank higher →
How Does DNTH Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, DNTH ranks #137 by Quality of Company score. CirclFi's QOC score of 5.9/10 evaluates 32 fundamental signals. A score of 5.9 reflects mixed fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
The Pharmaceutical Preparations sector introduces analytical considerations specific to biopharma enterprise businesses. For Dianthus Therapeutics, Inc., metrics like revenue per drug provide important context that general-purpose valuation models may underweight.
Is DNTH a Value Trap?
CirclFi's Value Trap algorithm assigns DNTH a score of 24/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Dianthus Therapeutics, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Dianthus Therapeutics, Inc. scores 5.9 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +95.3% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every DNTH valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across DNTH's 12 active models, average confidence is 33%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad